tiprankstipranks
Mineralys Therapeutics, Inc. (MLYS)
NASDAQ:MLYS
US Market
MLYS
Mineralys Therapeutics, Inc.
RESEARCH TOOLSreports

Mineralys Therapeutics, Inc. (MLYS) Income Statement

592 Followers

Mineralys Therapeutics, Inc. Income Statement

Last quarter (Q4 2025), Mineralys Therapeutics, Inc.'s total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Mineralys Therapeutics, Inc.'s net income was $-32.23M. See Mineralys Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -59.00K$ -43.00K$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 170.60M$ 192.40M$ 84.66M$ 31.48M$ 18.73M
Depreciation and Amortization
$ 59.00K$ 43.00K$ 0.00$ 0.00$ 0.00
EBITDA
$ -170.60M$ -192.36M$ -84.66M$ -31.48M$ -19.38M
Operating Income
$ -170.60M$ -192.40M$ -84.66M$ -31.48M$ -18.73M
Other Income/Expenses
$ 15.95M$ 14.59M$ 12.76M$ 1.68M$ -683.00K
Pretax Income
$ -154.65M$ -177.81M$ -71.90M$ -29.80M$ -19.41M
Net Income
$ -154.65M$ -177.81M$ -71.90M$ -29.80M$ -19.41M
Per Share Metrics
Basic EPS
$ -2.29$ -3.66$ -1.99$ -5.77$ -3.89
Diluted EPS
$ -2.29$ -3.66$ -1.99$ -5.77$ -3.89
Weighted Average Shares Outstanding
 67.66M 48.54M 36.19M 5.17M 4.98M
Weighted Average Shares Outstanding (Diluted)
 67.66M 48.54M 36.19M 5.17M 4.98M
Currency in USD

Mineralys Therapeutics, Inc. Earnings and Revenue History